Cargando…
Critical Question in Cardiovascular Risk: Can we use clinical trials to improve the outcomes of patients with hypertension?
Autor principal: | Kostis, John B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8710417/ https://www.ncbi.nlm.nih.gov/pubmed/34988555 http://dx.doi.org/10.1016/j.ijcrp.2021.200108 |
Ejemplares similares
-
Circumcision standards: can we improve further?
por: Donat, Roland
Publicado: (2014) -
Long-term BP variability: open questions in clinical practice
por: Del Pinto, Rita, et al.
Publicado: (2020) -
Do we really need another risk prediction rule? Yes, we do
por: Lo, Alexander X., et al.
Publicado: (2022) -
How can MCDA tools improve priority setting? Four critical questions
por: Norheim, Ole F.
Publicado: (2018) -
Commentary: “Lower is Better” — SPRINTing to STEPping up hypertension research? An historical perspective on hypertension trials
por: Yu, Yu-Ling, et al.
Publicado: (2021)